ArticleScientific reports2025
N-cadherin-mimetic 3D hydrogels program pro-regenerative and immunomodulatory states in human adipose-derived mesenchymal stem cells.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dynamic Tuning of MSC-Based Scaffolds for Neurological Protection After Brain or CNS Injury.Life (Basel, Switzerland) · 2026Review
- 3D-Mesenchymal stromal cells derived VASH2 alleviates oxidative stress-induced endothelial senescence by mediating α-tubulin detyrosination in systemic sclerosis.Journal of translational medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Mesenchymal stromal cell (MSC) therapies critically depend on culture systems that preserve stem cell identity while appropriately configuring immunomodulatory functions. Here, we investigated how a biomimetic three-dimensional (3D) hydrogel that presents the N-cadherin-derived HAVDI motif shapes the phenotype and inflammatory programming of human adipose-derived MSCs (ADMSCs). Self-assembled HAVDI-functionalized peptide amphiphile hydrogels formed nanofibrous, mechanically stable networks that supported high cell viability and sustained encapsulation. Across all conditions-including tissue culture plastic, micromass aggregates, and 2D/3D peptide formulations-flow cytometry showed that ADMSCs remained > 90% positive for canonical MSC markers CD73, CD90, and CD105, indicating global preservation of MSC surface phenotype, with peptide-modified environments modestly stabilizing marker expression relative to uncoated plastic. In 3D HAVDI hydrogels, gene expression profiling revealed robust upregulation of p120-catenin and β-catenin, together with increased transcription of matrix-remodeling and angiogenesis-related genes (MMP2, PLAU, VEGFR2), consistent with a pro-regenerative program. Notably, 3D HAVDI cultures displayed markedly elevated basal expression of multiple immunoregulatory cytokine genes (IL-1α, IL-1β, IL-8, IFN-γ, TNF-α, GM-CSF) under LPS-negative conditions, followed by a pronounced downregulation upon LPS challenge, suggestive of a tolerance-like, controlled inflammatory response rather than unchecked activation. Collectively, these findings show that HAVDI-functionalized 3D hydrogels provide a bioinstructive niche that maintains MSC phenotype while priming ADMSCs into a regenerative and tightly regulated immunomodulatory state, highlighting their potential as an advanced platform for stem cell-based tissue repair and immune modulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.